rs9767451

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_138459.5(NUS1):​c.-16T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.949 in 148,260 control chromosomes in the GnomAD database, including 67,057 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.95 ( 67057 hom., cov: 22)
Exomes 𝑓: 0.99 ( 587666 hom. )
Failed GnomAD Quality Control

Consequence

NUS1
NM_138459.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.860

Publications

10 publications found
Variant links:
Genes affected
NUS1 (HGNC:21042): (NUS1 dehydrodolichyl diphosphate synthase subunit) This gene encodes a type I single transmembrane domain receptor, which is a subunit of cis-prenyltransferase, and serves as a specific receptor for the neural and cardiovascular regulator Nogo-B. The encoded protein is essential for dolichol synthesis and protein glycosylation. This gene is highly expressed in non-small cell lung carcinomas as well as estrogen receptor-alpha positive breast cancer cells where it promotes epithelial mesenchymal transition. This gene is associated with the poor prognosis of human hepatocellular carcinoma patients. Naturally occurring mutations in this gene cause a congenital disorder of glycosylation and are associated with epilepsy. A knockout of the orthologous gene in mice causes embryonic lethality before day 6.5. Pseudogenes of this gene have been defined on chromosomes 13 and X. [provided by RefSeq, May 2017]
NUS1 Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 55, with seizures
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • progressive myoclonus epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital disorder of glycosylation, type IAA
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 6-117675655-T-C is Benign according to our data. Variant chr6-117675655-T-C is described in ClinVar as Benign. ClinVar VariationId is 1327053.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.992 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138459.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NUS1
NM_138459.5
MANE Select
c.-16T>C
5_prime_UTR
Exon 1 of 5NP_612468.1Q96E22

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NUS1
ENST00000368494.4
TSL:1 MANE Select
c.-16T>C
5_prime_UTR
Exon 1 of 5ENSP00000357480.3Q96E22
NUS1
ENST00000885063.1
c.-16T>C
5_prime_UTR
Exon 1 of 6ENSP00000555122.1
NUS1
ENST00000923852.1
c.-16T>C
5_prime_UTR
Exon 1 of 3ENSP00000593911.1

Frequencies

GnomAD3 genomes
AF:
0.949
AC:
140599
AN:
148162
Hom.:
67016
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.857
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.957
Gnomad ASJ
AF:
0.999
Gnomad EAS
AF:
0.842
Gnomad SAS
AF:
0.990
Gnomad FIN
AF:
0.982
Gnomad MID
AF:
0.990
Gnomad NFE
AF:
0.998
Gnomad OTH
AF:
0.956
GnomAD2 exomes
AF:
0.948
AC:
112478
AN:
118648
AF XY:
0.957
show subpopulations
Gnomad AFR exome
AF:
0.756
Gnomad AMR exome
AF:
0.914
Gnomad ASJ exome
AF:
0.997
Gnomad EAS exome
AF:
0.780
Gnomad FIN exome
AF:
0.972
Gnomad NFE exome
AF:
0.996
Gnomad OTH exome
AF:
0.978
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.987
AC:
1188454
AN:
1204086
Hom.:
587666
Cov.:
17
AF XY:
0.988
AC XY:
595258
AN XY:
602536
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.854
AC:
22913
AN:
26828
American (AMR)
AF:
0.926
AC:
32957
AN:
35608
Ashkenazi Jewish (ASJ)
AF:
0.998
AC:
23304
AN:
23348
East Asian (EAS)
AF:
0.841
AC:
29180
AN:
34710
South Asian (SAS)
AF:
0.994
AC:
75115
AN:
75574
European-Finnish (FIN)
AF:
0.981
AC:
36756
AN:
37462
Middle Eastern (MID)
AF:
0.993
AC:
3644
AN:
3670
European-Non Finnish (NFE)
AF:
0.999
AC:
914265
AN:
915432
Other (OTH)
AF:
0.978
AC:
50320
AN:
51454
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.392
Heterozygous variant carriers
0
583
1167
1750
2334
2917
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16924
33848
50772
67696
84620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.949
AC:
140689
AN:
148260
Hom.:
67057
Cov.:
22
AF XY:
0.948
AC XY:
68457
AN XY:
72192
show subpopulations
African (AFR)
AF:
0.857
AC:
34239
AN:
39940
American (AMR)
AF:
0.957
AC:
14397
AN:
15040
Ashkenazi Jewish (ASJ)
AF:
0.999
AC:
3460
AN:
3462
East Asian (EAS)
AF:
0.842
AC:
4122
AN:
4898
South Asian (SAS)
AF:
0.990
AC:
4570
AN:
4616
European-Finnish (FIN)
AF:
0.982
AC:
9837
AN:
10020
Middle Eastern (MID)
AF:
0.990
AC:
287
AN:
290
European-Non Finnish (NFE)
AF:
0.998
AC:
66917
AN:
67040
Other (OTH)
AF:
0.954
AC:
1970
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
278
556
834
1112
1390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.975
Hom.:
13074
Bravo
AF:
0.941

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Congenital disorder of glycosylation, type IAA (1)
-
-
1
Intellectual disability, autosomal dominant 55, with seizures (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
7.0
DANN
Benign
0.50
PhyloP100
-0.86
PromoterAI
-0.035
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9767451; hg19: chr6-117996818; COSMIC: COSV63844470; API